Cargando…

Animal Models of Hepatocellular Carcinoma Prevention

Hepatocellular carcinoma (HCC) is a deadly disease and therapeutic efficacy in advanced HCC is limited. Since progression of chronic liver disease to HCC involves a long latency period of a few decades, a significant window of therapeutic opportunities exists for prevention of HCC and improve patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shankaraiah, Ram C., Gramantieri, Laura, Fornari, Francesca, Sabbioni, Silvia, Callegari, Elisa, Negrini, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895981/ https://www.ncbi.nlm.nih.gov/pubmed/31739536 http://dx.doi.org/10.3390/cancers11111792

Ejemplares similares

MicroRNAs in Animal Models of HCC
por: Fornari, Francesca, et al.
Publicado: (2019)

MicroRNA involvement in hepatocellular carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2008)

Role of microRNAs in hepatocellular carcinoma: a clinical perspective
por: Callegari, Elisa, et al.
Publicado: (2013)

Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research
por: Fornari, Francesca, et al.
Publicado: (2022)

MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer
por: Callegari, Elisa, et al.
Publicado: (2018)

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2018)

TP53/MicroRNA Interplay in Hepatocellular Carcinoma
por: Pollutri, Daniela, et al.
Publicado: (2016)

MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2022)

Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma
por: Lupini, Laura, et al.
Publicado: (2016)

Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2014)

MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma
por: Gramantieri, Laura, et al.
Publicado: (2021)

MicroRNAs as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much is missing?
por: Gramantieri, Laura, et al.
Publicado: (2022)

Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus
por: Callegari, Elisa, et al.
Publicado: (2013)

miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model
por: Callegari, Elisa, et al.
Publicado: (2018)

LncRNAs as novel players in hepatocellular carcinoma recurrence
por: Gramantieri, Laura, et al.
Publicado: (2018)

Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma
por: Giovannini, Catia, et al.
Publicado: (2023)

miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs
por: Lupini, Laura, et al.
Publicado: (2013)

The Importance of microRNAs in RAS Oncogenic Activation in Human Cancer
por: Roncarati, Roberta, et al.
Publicado: (2019)

Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs
por: Giovannini, Catia, et al.
Publicado: (2021)

Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
por: Fornari, Francesca, et al.
Publicado: (2021)

Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives
por: Giovannini, Catia, et al.
Publicado: (2016)

miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
por: Callegari, Elisa, et al.
Publicado: (2022)

miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
por: Callegari, Elisa, et al.
Publicado: (2022)

The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma
por: Pollutri, Daniela, et al.
Publicado: (2018)

MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma
por: Bergamini, Christian, et al.
Publicado: (2023)

MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
por: Turato, Cristian, et al.
Publicado: (2019)

Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating Biomarkers
por: Gramantieri, Laura, et al.
Publicado: (2021)

c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma
por: Granito, Alessandro, et al.
Publicado: (2015)

Novel Virus Identification through Metagenomics: A Systematic Review
por: Bassi, Cristian, et al.
Publicado: (2022)

Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
por: Gramantieri, Laura, et al.
Publicado: (2022)

Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2014)

Direct Antiviral Treatments for Hepatitis C Virus Have Off-Target Effects of Oncologic Relevance in Hepatocellular Carcinoma
por: Giovannini, Catia, et al.
Publicado: (2020)

Advances in experimental animal models of hepatocellular carcinoma
por: Li, Jing, et al.
Publicado: (2023)

miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eμ-TCL1 mouse model
por: Bresin, Antonella, et al.
Publicado: (2015)

microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review
por: Maranini, Beatrice, et al.
Publicado: (2022)

Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma
por: Carloni, Riccardo, et al.
Publicado: (2023)

Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2017)

Hepatocellular Carcinoma Prevention in the Era of Hepatitis C Elimination
por: Lazarus, Jeffrey V., et al.
Publicado: (2023)

Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment
por: Macek Jilkova, Zuzana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hem7vr5u0p3e01t4qc2t8j3hol